Concord Medical Services Holdings Limited Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (24)

Latest Posts

About This Stock More About This Stock
Week In Review: Concord Medical Raises $240 Million For China Radiology Services
Article By: ChinaBio® Today
Saturday, April 7, 2018 4:30 PM EST
Concord Medical Services announced that CICC Capital led an investment of between $238 million and $286 million in Concord’s subsidiary Beijing Meizhong Jiahe Hospital Management. The investors will hold 37.5% to 41.9% of Meizhong Jiahe's equity.
In this article: CCM, LLY
Read
Week In Review: China's Sanpower Pays $820M For Provenge, A Prostate Immunotherapy
Article By: ChinaBio® Today
Saturday, January 14, 2017 12:58 PM EST
Sanpower Group, a China conglomerate, paid $820 million to acquire Dendreon, which makes Provenge, the world's first immunotherapy, from Valeant Pharma.
In this article: CCM, VRX, KITE, ABBV, MRK
Read
Week In Review: New Deals Fund China Life Science Innovation
Article By: ChinaBio® Today
Saturday, September 3, 2016 1:30 PM EST
Beijing Allcure Medical Technology, a radiology oncology startup developing big data/cloud computing applications, raised $27 million in an A+ funding round.
In this article: CCM, SVA
Read
Week In Review: China Bridge Capital Announces $1.5 Billion Precision Medicine Fund
Article By: ChinaBio® Today
Saturday, July 16, 2016 12:24 PM EST
China Bridge Capital, a Beijing financial services firm, invested $45 million in iCarbonX, the big data/AI healthcare start-up that raised $155 million in a Series A at a $1 billion valuation earlier this year.
In this article: CCM, CRXM
Read
Week In Review: Xinbang Pharma Acquires Chinese Peptide Co. For $323 Million
Article By: ChinaBio® Today
Saturday, May 9, 2015 3:54 PM EST
Bayer AG announced that the CFDA has approved Xarelto (rivaroxaban), a once-daily oral anticoagulant, for two new anti-clotting indications: strokes and deep vein thrombosis.
In this article: BAX, MACK, BAYN, CCM, QGEN, AZN, PVCT
Read

PARTNER HEADLINES

Latest Tweets for $CCM

No tweets yet!